Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Credit Suisse Maintains Outperform on UiPath, Maintains $27.5 Price Target

Credit Suisse Maintains Outperform on UiPath, Maintains $27.5 Price Target

Credit Suisse analyst Sami Badri maintains UiPath (NYSE:PATH) with a Outperform and maintains $27.5 price target.

byBenzinga Newsdesk

March 17, 2023

1 minute read

Credit Suisse analyst Sami Badri maintains UiPath (NYSE:PATH) with a Outperform and maintains $27.5 price target.

News
Tech

Apple Could Bump Up All iPhone 15 Models To A Higher Resolution Camera

By Rounak Jain

June 14, 7:06 AM

Apple is expected to bump up all the iPhone 15 models to a higher resolution camera when it launches these new iPhones in August.

AAPL

Analyst Ratings

Analyst Ratings for Ambarella

By Benzinga Insights

May 24, 10:01 AM

Over the past 3 months, 12 analysts have published their opinion on Ambarella (NASDAQ:AMBA) stock. These analysts are…

AMBA

What’s Going On With Taiwan Semiconductor Stock Friday?

By Anusuya Lahiri

November 10, 10:13 AM

Taiwan Semiconductor Manufacturing Co (NASDAQ: TSM) is trading higher Friday as it reported a 34.8% month-on-month topline

AAPL

What’s Happening With Eliem Therapeutics Shares Today?

By Vandana Singh

July 20, 12:08 PM

Eliem Therapeutics Inc (NASDAQ: ELYM) shares are trading higher after the company completed a review of its business, including the status of its programs,

ELYM

Credit Suisse Maintains Outperform on UiPath, Maintains $27.5 Price Target

Related Posts

Apple Could Bump Up All iPhone 15 Models To A Higher Resolution Camera

Analyst Ratings for Ambarella

What’s Going On With Taiwan Semiconductor Stock Friday?

What’s Happening With Eliem Therapeutics Shares Today?